Reduced Graphene-Oxide Transducers for Biosensing Applications Beyond the Debye-Screening Limit

Xiaoling Lu, Anna Miodek, Walid Munief, Pawan Jolly, Vivek Pachauri, Xianping Chen, Pedro Estrela, Sven Ingebrandt

Research output: Contribution to journalArticle

2 Citations (Scopus)
3 Downloads (Pure)

Abstract

In the field of label-free biosensing, various transducer materials and strategies are under investigation to overcome the Debye-screening limitation of charged biomolecules. We demonstrate an in-line, impedimetric aptasensor with reduced graphene-oxide (rGO) thin films as transducers to detect prostate specific antigens (PSA) in a physiological buffer solution. Unlike classical electrochemical impedance spectroscopy (EIS), this direct, label-free and fully-electronic biosensor approach does not need any redox markers. As specific capture molecules, short anti-PSA aptamers ensured a close binding of the target molecules to the transducer surfaces. Results showed a limit of detection smaller than 33 pM of PSA and a wide detection range from 0.033 to 330 nM fully covering the clinically relevant range of PSA (0.115–0.290 nM). This promising performance can be attributed to the bipolar electronic transport characteristics of the ultra-thin rGO layers similar to pristine graphene. The attachment of target biomolecules to the films changes the resistance of the rGO thin films. Such an in-line EIS configuration with rGO thin films opens promising prospects for biosensing beyond the Debye-screening limitation, which is a major challenge for conventional semiconductor field-effect devices towards clinical applications.

Original languageEnglish
Pages (from-to)352-359
Number of pages8
JournalBiosensors and Bioelectronics
Volume130
Early online date14 Sep 2018
DOIs
Publication statusPublished - 1 Apr 2019

Fingerprint

Graphite
Transducers
Oxides
Graphene
Prostate-Specific Antigen
Antigens
Screening
Oxide films
Dielectric Spectroscopy
Biomolecules
Electrochemical impedance spectroscopy
Field effect semiconductor devices
Thin films
Labels
Semiconductors
Molecules
Biosensing Techniques
Biosensors
Oxidation-Reduction
Limit of Detection

Keywords

  • Aptasensor
  • Debye-screening limitation
  • In-line electrochemical impedance spectroscopy
  • Reduced graphene-oxide thin films

ASJC Scopus subject areas

  • Biotechnology
  • Biophysics
  • Biomedical Engineering
  • Electrochemistry

Cite this

Lu, X., Miodek, A., Munief, W., Jolly, P., Pachauri, V., Chen, X., ... Ingebrandt, S. (2019). Reduced Graphene-Oxide Transducers for Biosensing Applications Beyond the Debye-Screening Limit. Biosensors and Bioelectronics, 130, 352-359. https://doi.org/10.1016/j.bios.2018.09.045

Reduced Graphene-Oxide Transducers for Biosensing Applications Beyond the Debye-Screening Limit. / Lu, Xiaoling; Miodek, Anna; Munief, Walid; Jolly, Pawan; Pachauri, Vivek; Chen, Xianping; Estrela, Pedro; Ingebrandt, Sven.

In: Biosensors and Bioelectronics, Vol. 130, 01.04.2019, p. 352-359.

Research output: Contribution to journalArticle

Lu, Xiaoling ; Miodek, Anna ; Munief, Walid ; Jolly, Pawan ; Pachauri, Vivek ; Chen, Xianping ; Estrela, Pedro ; Ingebrandt, Sven. / Reduced Graphene-Oxide Transducers for Biosensing Applications Beyond the Debye-Screening Limit. In: Biosensors and Bioelectronics. 2019 ; Vol. 130. pp. 352-359.
@article{88613e3eaff74766926786536408b678,
title = "Reduced Graphene-Oxide Transducers for Biosensing Applications Beyond the Debye-Screening Limit",
abstract = "In the field of label-free biosensing, various transducer materials and strategies are under investigation to overcome the Debye-screening limitation of charged biomolecules. We demonstrate an in-line, impedimetric aptasensor with reduced graphene-oxide (rGO) thin films as transducers to detect prostate specific antigens (PSA) in a physiological buffer solution. Unlike classical electrochemical impedance spectroscopy (EIS), this direct, label-free and fully-electronic biosensor approach does not need any redox markers. As specific capture molecules, short anti-PSA aptamers ensured a close binding of the target molecules to the transducer surfaces. Results showed a limit of detection smaller than 33 pM of PSA and a wide detection range from 0.033 to 330 nM fully covering the clinically relevant range of PSA (0.115–0.290 nM). This promising performance can be attributed to the bipolar electronic transport characteristics of the ultra-thin rGO layers similar to pristine graphene. The attachment of target biomolecules to the films changes the resistance of the rGO thin films. Such an in-line EIS configuration with rGO thin films opens promising prospects for biosensing beyond the Debye-screening limitation, which is a major challenge for conventional semiconductor field-effect devices towards clinical applications.",
keywords = "Aptasensor, Debye-screening limitation, In-line electrochemical impedance spectroscopy, Reduced graphene-oxide thin films",
author = "Xiaoling Lu and Anna Miodek and Walid Munief and Pawan Jolly and Vivek Pachauri and Xianping Chen and Pedro Estrela and Sven Ingebrandt",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.bios.2018.09.045",
language = "English",
volume = "130",
pages = "352--359",
journal = "Biosensors and Bioelectronics",
issn = "0956-5663",
publisher = "Elsevier",

}

TY - JOUR

T1 - Reduced Graphene-Oxide Transducers for Biosensing Applications Beyond the Debye-Screening Limit

AU - Lu, Xiaoling

AU - Miodek, Anna

AU - Munief, Walid

AU - Jolly, Pawan

AU - Pachauri, Vivek

AU - Chen, Xianping

AU - Estrela, Pedro

AU - Ingebrandt, Sven

PY - 2019/4/1

Y1 - 2019/4/1

N2 - In the field of label-free biosensing, various transducer materials and strategies are under investigation to overcome the Debye-screening limitation of charged biomolecules. We demonstrate an in-line, impedimetric aptasensor with reduced graphene-oxide (rGO) thin films as transducers to detect prostate specific antigens (PSA) in a physiological buffer solution. Unlike classical electrochemical impedance spectroscopy (EIS), this direct, label-free and fully-electronic biosensor approach does not need any redox markers. As specific capture molecules, short anti-PSA aptamers ensured a close binding of the target molecules to the transducer surfaces. Results showed a limit of detection smaller than 33 pM of PSA and a wide detection range from 0.033 to 330 nM fully covering the clinically relevant range of PSA (0.115–0.290 nM). This promising performance can be attributed to the bipolar electronic transport characteristics of the ultra-thin rGO layers similar to pristine graphene. The attachment of target biomolecules to the films changes the resistance of the rGO thin films. Such an in-line EIS configuration with rGO thin films opens promising prospects for biosensing beyond the Debye-screening limitation, which is a major challenge for conventional semiconductor field-effect devices towards clinical applications.

AB - In the field of label-free biosensing, various transducer materials and strategies are under investigation to overcome the Debye-screening limitation of charged biomolecules. We demonstrate an in-line, impedimetric aptasensor with reduced graphene-oxide (rGO) thin films as transducers to detect prostate specific antigens (PSA) in a physiological buffer solution. Unlike classical electrochemical impedance spectroscopy (EIS), this direct, label-free and fully-electronic biosensor approach does not need any redox markers. As specific capture molecules, short anti-PSA aptamers ensured a close binding of the target molecules to the transducer surfaces. Results showed a limit of detection smaller than 33 pM of PSA and a wide detection range from 0.033 to 330 nM fully covering the clinically relevant range of PSA (0.115–0.290 nM). This promising performance can be attributed to the bipolar electronic transport characteristics of the ultra-thin rGO layers similar to pristine graphene. The attachment of target biomolecules to the films changes the resistance of the rGO thin films. Such an in-line EIS configuration with rGO thin films opens promising prospects for biosensing beyond the Debye-screening limitation, which is a major challenge for conventional semiconductor field-effect devices towards clinical applications.

KW - Aptasensor

KW - Debye-screening limitation

KW - In-line electrochemical impedance spectroscopy

KW - Reduced graphene-oxide thin films

UR - http://www.scopus.com/inward/record.url?scp=85054030490&partnerID=8YFLogxK

U2 - 10.1016/j.bios.2018.09.045

DO - 10.1016/j.bios.2018.09.045

M3 - Article

VL - 130

SP - 352

EP - 359

JO - Biosensors and Bioelectronics

JF - Biosensors and Bioelectronics

SN - 0956-5663

ER -